Is 4-(3-(2-Chlorophenothiazin-10-yl)propyl)-1-piperazineethanol Safe in Breastfeeding

I am a breastfeeding mother and i want to know if it is safe to use 4-(3-(2-Chlorophenothiazin-10-yl)propyl)-1-piperazineethanol? Is 4-(3-(2-Chlorophenothiazin-10-yl)propyl)-1-piperazineethanol safe for nursing mother and child? Does 4-(3-(2-Chlorophenothiazin-10-yl)propyl)-1-piperazineethanol extracts into breast milk? Does 4-(3-(2-Chlorophenothiazin-10-yl)propyl)-1-piperazineethanol has any long term or short term side effects on infants? Can 4-(3-(2-Chlorophenothiazin-10-yl)propyl)-1-piperazineethanol influence milk supply or can 4-(3-(2-Chlorophenothiazin-10-yl)propyl)-1-piperazineethanol decrease milk supply in lactating mothers?

One reportedly case of use by a mother for 3,5 months (8 - 12 mg x 2 / daily) without harm effects on the child. Check-up for lethargy or dyskinetic symptoms.

Limited information indicates that maternal doses of 4-(3-(2-Chlorophenothiazin-10-yl)propyl)-1-piperazineethanol up to 24 mg daily produce low levels in milk. Very limited long-term follow-up data indicate no adverse developmental effects when other phenothiazines are used alone. Monitor the infant for excessive drowsiness during breastfeeding and for developmental milestones, especially if other antipsychotics are used concurrently.

One infant was breastfed from 1 month to 4.5 months of age during maternal intake of 4-(3-(2-Chlorophenothiazin-10-yl)propyl)-1-piperazineethanol 16 mg daily. The infant grew normally and no adverse drug effects were seen.[1]

Galactorrhea has been reported with 4-(3-(2-Chlorophenothiazin-10-yl)propyl)-1-piperazineethanol.[2][3] Hyperprolactinemia appears to be the cause of the galactorrhea.[4][5][6] The hyperprolactinemia is caused by the drug's dopamine-blocking action in the tuberoinfundibular pathway.[7] The prolactin level in a mother with established lactation may not affect her ability to breastfeed.